This session will discuss how increased globalization of clinical development and continued advancement in the clinical trial environment, standard of care, and regulations has brought challenges to successfully execute studies with quality and cost-effectiveness in emerging markets. It is important to evaluate cultural attributes, local health care regulations, site/vendor capabilities, and identify the critical quality factors up-front to ensure a high quality trial that will withstand regulatory scrutiny.